Assessment of Serum Level of Brain-Derived Neurotrophic Factor in Pediatric Alopecia Areata: A Case-Control Study
September 2025
Research cited in this study
8 / 8 results
research European Expert Consensus Statement on the Systemic Treatment of Alopecia Areata
Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.
research Serum Brain-Derived Neurotrophic Factor and Vitamin D: Two Concordant Players Controlling Depression Among Alopecia Areata and Vitiligo Patients: A Case-Control Study
Low levels of BDNF and vitamin D are linked to higher depression in alopecia areata and vitiligo patients.
research Correlation Between Serum Brain-Derived Neurotrophic Factor Level and Depression Severity in Alopecia Areata Patients
Lower BDNF levels link to worse depression in alopecia areata patients.
research Impact of Pediatric Alopecia Areata on Quality of Life of Patients and Their Family Members: A Nationwide Multicenter Questionnaire Study
Severe pediatric alopecia areata worsens quality of life for patients and families.
research The Alopecia Areata Investigator Global Assessment Scale: A Measure for Evaluating Clinically Meaningful Success in Clinical Trials
The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.
research All-Cause and Cause-Specific Mortality Risks Associated With Alopecia Areata
People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.
research Alopecia Areata: A Multifactorial Autoimmune Condition
Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.
research Alopecia Areata: Overview and Insights from January 2018
Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.